The programmable nuclease can replace restriction enzymes, enables cloning of large genomic sequences, and can deplete unwanted DNA species.
Heat-Seq, scheduled to launch in the second quarter, uses empirically tested molecular inversion probes.
A team of scientists believe that exosomal miRNAs holds promise to be significant biomarkers for Alzheimer's disease.
Three individuals in a 17th century burial carried genetic signatures associated with Bantu- and non-Bantu speaking populations in parts of Cameroon, Nigeria, and Ghana.
Illumina's Nextera kits and NGS technology will be used in the the National Lung Matrix Trial being run by Cancer Research UK.
Agilent Technologies said today that it has acquired Halo Genomics, a privately held Uppsala, Sweden-based provider of sample prep tools for next-generation sequencing.
By Ben Butkus
By a GenomeWeb staff reporter
Boreal's prototype platform can differentiate and enrich for sequences that differ by one nucleotide from as many as 10,000 copies of background DNA. The company believes it has potential for use in clinical applications.
Ambry is Roche NimbleGen's first service provider in the US offering the SeqCap EZ Human Exome product.
The president of France's National Research Agency has resigned, according to Nature News.
A senator wants a "right-to-try" provision in the US Food and Drug Administration funding bill, but an ethicist says at Stat News that it would undermine the role of clinical trials.
In PNAS this week: red algae Porphyra umbicalis genome, deep neural network model for sequencing peptides, and more.
The Guardian's Barbara Ellen has tried out some DNA testing services to see whether they provide valuable information.